
Protagenic Therapeutics Inc (PTIX)
NASDAQ
The current PTIX market cap is 1.95M. The company's latest EPS is USD -9.3809 and P/E is -0.36.
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -1.74M | -1.67M | -652k | -1.64M | -1.45M |
Net Income | -1.72M | -1.61M | -641k | -1.55M | -1.44M |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -2.55M | -4.14M | -3.56M | -4.53M | -5.7M |
Net Income | -2.55M | -4.52M | -3.56M | -5M | -5.53M |
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 2.58M | 1.47M | 1.51M | 1.96M | 989k |
Total Liabilities | 447k | 674k | 789k | 943k | 1.08M |
Total Equity | 2.13M | 793k | 719k | 1.01M | -88k |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 879k | 11.06M | 8.04M | 4.32M | 1.96M |
Total Liabilities | 2.03M | 1.12M | 1.12M | 655k | 943k |
Total Equity | -1.15M | 9.94M | 6.92M | 3.67M | 1.01M |
Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -1.66M | -3.21M | -3.4M | -4.22M | -1.07M |
Investing | 1.2M | 2.8M | 2.8M | 2.8M | N/A |
Financing | N/A | 45k | 361k | 1.96M | 103k |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -1.35M | -2.8M | -1.99M | -3.7M | -4.22M |
Investing | N/A | -9.91M | 1.6M | 4.78M | 2.8M |
Financing | 1.22M | 12.58M | N/A | N/A | 1.96M |
Market Cap | 1.95M |
Price to Earnings Ratio | -0.36 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 1.07 |
Price to Book Ratio | 1.94 |
Dividend Yield | - |
Shares Outstanding | 588.96k |
Average Volume (1 week) | 107.87k |
Average Volume (1 Month) | 5.7M |
52 Week Change | -73.12% |
52 Week High | 15.82 |
52 Week Low | 2.35 |
Spread (Intraday) | 0.05 (1.49%) |
Company Name | Protagenic Therapeutics Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.protagenic.com |
Industry | books: pubg, pubg & printing (2731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.